Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.
Jun-Xu Li, Wouter Koek, Kenner C Rice, Charles P France
The Journal of pharmacology and experimental therapeutics April 1, 2010 DOI: 10.1124/jpet.109.163451 via PubMed
Summary
AI-generated from the abstractSerotonin (5-HT)1A receptor agonists attenuated the effects of the 5-HT2A receptor agonist DOM in rhesus monkeys but not in rats, indicating a species difference in how these receptor systems interact. DOM and other 5-HT2A agonists produced similar discriminative stimulus effects in both species, and these effects were blocked by a 5-HT2A antagonist. The 5-HT1A agonists 8-OH-DPAT and F13714 reduced DOM's effects only in monkeys, an effect prevented by a 5-HT1A antagonist. The findings suggest that while the DOM stimulus is mediated by 5-HT2A receptors in both species, the modulatory role of 5-HT1A receptors differs markedly between rats and monkeys, which has implications for studying drugs with multiple mechanisms.
Study at a glance
| Characteristics | Comparative animal model study Peer reviewed |
|---|---|
| Sample size | 11 |
| Population | 8 rats and 3 rhesus monkeys |
| Interventions | 1-(2 5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) 8-hydroxy-2-(di-n-propylamino) tetralin hydrochloride (8-OH-DPAT) 3-chloro-4-fluorophenyl-(4-fluoro-4-([(5-methyl-6-methylaminopyridin-2-ylmethyl) amino) methyl] piperidin-1-yl) methanone (F13714) 2 5-dimethoxy-4-n-propylthiophenethylamine (2C-T-7) dipropyltryptamine (DPT) N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide (WAY 100635) |
| Dose | 0.56 mg/kg i.p. DOM for rats, 0.32 mg/kg s.c. DOM for monkeys |
| Keywords | Species differences Interspecies variation Comparative pharmacology Animal model differences Species-specific effects |
| Citations | 17 |
| Key finding | 5-HT1A receptor agonists attenuated the discriminative stimulus effects of the 5-HT2A agonist DOM in monkeys but not in rats, revealing a species difference in 5-HT receptor interactions. |
Abstract
Although many drugs act by indirectly stimulating multiple receptors (e.g., reuptake inhibitors), relatively little is known about interactions between agonism at different receptors. This study compared the effect of serotonin (5-HT)(1A) receptor agonists with the discriminative stimulus effects of the 5-HT(2A) receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats and rhesus monkeys. Eight rats discriminated 0.56 mg/kg i.p. DOM and responded under a fixed ratio (FR) 10 schedule of food presentation, whereas three rhesus monkeys discriminated 0.32 mg/kg s.c. DOM and responded under an FR 5 schedule of stimulus shock termination. DOM and the 5-HT(2A) receptor agonists 2,5-dimethoxy-4-n-propylthiophenethylamine (2C-T-7) and dipropyltryptamine (DPT), but not the 5-HT(1A) receptor agonists 8-hydroxy-2-(di-n-propylamino) tetralin hydrochloride (8-OH-DPAT) and 3-chloro-4-fluorophenyl-(4-fluoro-4-([(5-methyl-6-methylaminopyridin-2-ylmethyl) amino) methyl] piperidin-1-yl) methanone (F13714), occasioned responding on the DOM-associated lever in rats and monkeys. Both 8-OH-DPAT and F13714 attenuated the discriminative stimulus effects of DOM in monkeys but not in rats; these effects of 8-OH-DPAT and F13714 were prevented by the 5-HT(1A) receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide (WAY 100635). DPT and 2C-T-7 enhanced the discriminative stimulus effects of DOM in rats and monkeys in an additive manner. Taken together, the results suggest that the DOM discriminative stimulus is pharmacologically similar and mediated by 5-HT(2A) receptors in rats and monkeys; however, the ability of 5-HT(1A) receptor agonists to modify the effects of DOM is markedly different between these species. These results indicate possible differences in the neurobiology of 5-HT systems that could be important for studying drugs that have multiple mechanisms of action (e.g., reuptake inhibitors that indirectly stimulate multiple receptors).